Amarin Corp Plc (AMRN)

[Jvee]

“Now the courts are forced to address this issue to restore balance, fairness and protection to innovators and protect patients from the evergreening of patents and high brand drug costs.”

Based on the results of Amarin’s several court cases in recent years, from District Courts to the Supreme Court, I see no evidence of interest in fairness or concern, for protection of patent rights or patients for that matter - unfortunately for us investors.